Otros idiomas Scandinavian ChemoTech AB

Acciones

CMOTEC B

SE0009242654

Diferido Nasdaq Stockholm Otros sitios de cotización 10:06:29 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
2,22 ^SEK	-0,45 %		+1,37 %	-17,78 %

22/04	Scandinavian Chemotech AB (publ) obtiene la aprobación de la tercera y última solicitud de patente en India	CI
10/04	Scandinavian ChemoTech AB (publ) logra avances al obtener la protección de dos patentes esenciales en la India	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ChemoTech obtain approval of the third and last patent application in India	22/04
Scandinavian Chemotech AB Obtains Approval of the Third and Last Patent Application in India	22/04
ChemoTech attains progress by obtaining patent protection for two essential patents in India	10/04
Scandinavian ChemoTech AB Attains Progress by Obtaining Patent Protection for Two Essential Patents in India	10/04
Scandinavian ChemoTech's Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence	05/04
ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic	27/03
Scandinavian ChemoTech Secures Order from the Largest European Equine Clinic	27/03
IQwave™ Receives Certification for Tumour Treatment in Singapore	25/03
Scandinavian ChemoTech AB's IQwave Receives Certification for Tumour Treatment in Singapore	25/03
Scandinavian ChemoTech - Weathering the storm	22/03
ChemoTech signs new agreement with a private hospital & medical college	20/03
Scandinavian ChemoTech AB Signs New Agreement with Chhatrapati Shivaji Subharti Hospital & Medical College	20/03
ChemoTech adapts its strategy and short-term targets for Human Care	20/03
Scandinavian ChemoTech AB (publ) Year-End Report January - December 2023 - Executive Summary	05/03
Scandinavian ChemoTech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Scandinavian ChemoTech AB Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
New order received for the Innovative TSE Cancer Treatment Technology	12/02
Scandinavian ChemoTech AB Receives Order for USD 30,000 from One of Its Largest Clients in the United States	12/02
Invitation to Presentation on the recent Ethics Committee Approval and Clinical Strategy	26/01
Ground-breaking milestone in Head & Neck cancer treatment achieved	26/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Scandinavian ChemoTech AB

Acciones

CMOTEC B

SE0009242654

Otros idiomas

Filtros